Category: 6. Health

Continue Reading

  • Cross-reactivity IgG, viral load, severity and vaccination outcome as an approach for understanding humoral immune response against SARS-CoV-2 | BMC Infectious Diseases

    Cross-reactivity IgG, viral load, severity and vaccination outcome as an approach for understanding humoral immune response against SARS-CoV-2 | BMC Infectious Diseases

  • Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92.

    CAS 
    PubMed 

    Google Scholar 

  • Masters PS. The molecular biology of coronaviruses. Adv Virus…

  • Continue Reading

  • Could AI help defeat antibiotic-resistant superbugs? UK scientists are trying to find out

    Could AI help defeat antibiotic-resistant superbugs? UK scientists are trying to find out

    Published on

    Scientists in the United Kingdom will soon use artificial intelligence (AI) to combat the rising threat…

    Continue Reading

  • CRISPR disruption of NRF2 re-sensitises tumours to chemo

    CRISPR disruption of NRF2 re-sensitises tumours to chemo

    Researchers have shown that using CRISPR to disable the NRF2 gene can restore chemotherapy sensitivity and slow tumour growth.


    Scientists at ChristianaCare’s Gene Editing Institute have reported a new discovery in cancer…

    Continue Reading

  • Ultra-Processed Foods Increase Prediabetes Risk in Youth

    Ultra-Processed Foods Increase Prediabetes Risk in Youth

    A NEW study shows that higher consumption of ultra-processed foods (UPFs) in young adults is associated with increased risk of prediabetes and impaired glucose regulation.

    Ultra-Processed Foods and Youth Glucose Health

    Ultra-processed foods,…

    Continue Reading

  • Just a moment…

    Just a moment…

    Continue Reading

  • World-first lung cancer prevention vaccine “LungVax” enters phase 1 trial

    World-first lung cancer prevention vaccine “LungVax” enters phase 1 trial

    image: ©3dMediSphere | iStock

    Cancer Research UK is backing a £2.06 million, first-in-human trial of LungVax, a preventative vaccine designed to prime the immune system against early lung cancer, a potential…

    Continue Reading